Qorvo this week said it received FDA emergency use authorization for its Omnia SARS-CoV-2 antigen test. The diagnostic platform uses high-frequency bulk acoustic wave (BAW) sensors to test for COVID-19 antigens in approximately 20 minutes, according to the company. BAW sensors enable a low limit of detection levels that are similar to molecular testing capability. […]